Prof. Dr. MUSTAFA ÖZEN

Yayın Ağı

Makaleler 84

1. Molecular Genetic Approach to Craniosynostosis Patients and Whole Genome Array CGH Analysis of Nonsyndromic Cases

Gezdirici A., Kafadar A. M., Ozen M.

GAZI MEDICAL JOURNAL , cilt.32, sa.2, ss.208-212, 2021 (ESCI, Scopus)

2. Kallikrein gene family as biomarkers for recurrent prostate cancer

Boyukozer F. B., Tanoglu E. G., Ozen M., Ittmann M., Asian E. S.

CROATIAN MEDICAL JOURNAL , cilt.61, sa.5, ss.450-456, 2020 (SCI-Expanded, Scopus)

3. Revealing the functions of novel mutations in RAB3GAP1 in Martsolf and Warburg micro syndromes

Koparir A., Karatas O. F., Yilmaz S. S., SUER İ., Ozer B., Yuceturk B., et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A , cilt.179, sa.4, ss.579-587, 2019 (SCI-Expanded, Scopus)

4. MicroRNAs as prognostic markers in prostate cancer

SUER İ., Guzel E., Karatas O. F., Creighton C. J., Ittmann M., Ozen M.

PROSTATE , cilt.79, sa.3, ss.265-271, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer

Karatas O. F., Wang J., Shao L., ÖZEN M., Zhang Y., Creighton C. J., et al.

ONCOTARGET , cilt.8, sa.36, ss.60243-60256, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy

Pashaei E., Pashaei E., Ahmady M., Ozen M., AYDIN N.

PLOS ONE , cilt.12, sa.6, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Splice site identification in human genome using random forest

Pashaei E., Ozen M., AYDIN N.

HEALTH AND TECHNOLOGY , cilt.7, sa.1, ss.141-152, 2017 (ESCI, Scopus) Sürdürülebilir Kalkınma

8. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens

Karatas O. F., SUER İ., Yuceturk B., YILMAZ M. Y., ÖZ A. B., Guven G., et al.

BMC CANCER , cilt.16, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Plasticity-Promoting Effect of Melatonin After Experimental Cerebral Ischemia

Kilic U., ELİBOL B., Beker M. C., Caglayan A. B., Tasa B. A., Beker M., et al.

ACTA PHYSIOLOGICA , cilt.218, ss.67-68, 2016 (SCI-Expanded, Scopus)

10. A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets

Pashaei E., Guzel E., Ozgurses M. E., Demirel G., AYDIN N., Ozen M.

PLOS ONE , cilt.11, sa.9, 2016 (SCI-Expanded, Scopus)

11. Differential expression of LOXL4 in normal and tumour tissue samples of laryngeal squamous cell carcinoma

YILMAZ M., SUER İ., KARATAŞ Ö., CANSIZ H., ÖZEN M.

CLINICAL OTOLARYNGOLOGY , cilt.41, sa.3, ss.206-210, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. The role of ATP-binding cassette transporter genes in the progression of prostate cancer

Karatas O. F., Guzel E., Duz M. B., Ittmann M., ÖZEN M.

PROSTATE , cilt.76, sa.5, ss.434-444, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study

Duz M. B., Karatas O. F., Guzel E., Turgut N. F., YILMAZ M. Y., Creighton C. J., et al.

CELLULAR ONCOLOGY , cilt.39, sa.2, ss.187-193, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells

Karatas O. F., SUER İ., Yuceturk B., YILMAZ M. Y., Hajiyev Y., Creighton C. J., et al.

TUMOR BIOLOGY , cilt.37, sa.3, ss.4183-4192, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Role of miR-145 in human laryngeal squamous cell carcinoma

Karatas O. F., Yuceturk B., SUER İ., YILMAZ M. Y., CANSIZ H., Solak M., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.38, sa.2, ss.260-266, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Revealing the function of a novel splice-site mutation of CHD7 in CHARGE syndrome

Lee B., Duz M. B., Sagong B., Koparir A., Lee K., Choi J. Y., et al.

GENE , cilt.576, sa.2, ss.776-781, 2016 (SCI-Expanded, Scopus)

17. The altered promoter methylation of oxytocin receptor gene in autism

Yuksel M. E., Yuceturk B., Karatas O. F., ÖZEN M., Dogangung B.

JOURNAL OF NEUROGENETICS , cilt.30, sa.3-4, ss.280-284, 2016 (SCI-Expanded, Scopus)

18. MiR-221 as a Pre- and Postoperative Plasma Biomarker for Larynx Cancer Patients

Yilmaz S. S., Guzel E., Karatas O. F., YILMAZ M. Y., Creighton C. J., ÖZEN M.

LARYNGOSCOPE , cilt.125, sa.12, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension

Cengiz M., Yavuzer S., Avci B. K., Yuruyen M., YAVUZER H., Dikici S. A., et al.

CLINICAL AND EXPERIMENTAL HYPERTENSION , cilt.37, sa.8, ss.643-649, 2015 (SCI-Expanded, Scopus)

20. Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease

Karaca E., Harel T., Pehlivan D., Jhangiani S. N., Gambin T., Akdemir Z. C., et al.

NEURON , cilt.88, sa.3, ss.499-513, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Novel POC1A mutation in primordial dwarfism reveals new insights for centriole biogenesis

Koparir A., Karatas O. F., Yuceturk B., Yuksel B., Bayrak A. O., Gerdan O. F., et al.

HUMAN MOLECULAR GENETICS , cilt.24, sa.19, ss.5378-5387, 2015 (SCI-Expanded, Scopus)

22. Novel MASP1 mutations are associated with an expanded phenotype in 3MC1 syndrome

Atik T., Koparir A., Bademci G., Foster J., Altunoglu U., MUTLU G. A., et al.

ORPHANET JOURNAL OF RARE DISEASES , cilt.10, 2015 (SCI-Expanded, Scopus)

23. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues

YILMAZ M. Y., Karatas O. F., Yuceturk B., Dag H., YENER H. M., ÖZEN M.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.37, sa.9, ss.1344-1348, 2015 (SCI-Expanded, Scopus)

24. Whole-exome sequencing revealed two novel mutations in Usher syndrome

Koparir A., Karatas O. F., Atayoglu A. T., Yuksel B., Sagiroglu M. S., SEVEN M., et al.

GENE , cilt.563, sa.2, ss.215-218, 2015 (SCI-Expanded, Scopus)

25. Differential Expression of Hypertension-Associated MicroRNAs in the Plasma of Patients With White Coat Hypertension

Cengiz M., Karatas O. F., Koparir E., Yavuzer S., Ali C., YAVUZER H., et al.

MEDICINE , cilt.94, sa.13, 2015 (SCI-Expanded, Scopus)

26. Report of a family with craniofrontonasal syndrome

Ozyilmaz B., Gezdirici A., ÖZEN M., Kalenderer O.

CLINICAL DYSMORPHOLOGY , cilt.24, sa.2, ss.79-83, 2015 (SCI-Expanded, Scopus)

27. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer

Guzel E., KARATAŞ Ö., Semercioz A., Ekici S., Aykan S., Yentur S., et al.

INTERNATIONAL JOURNAL OF CANCER , cilt.136, sa.4, ss.875-879, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes

Yuan B., Pehlivan D., Karaca E., Patel N., Charng W., Gambin T., et al.

JOURNAL OF CLINICAL INVESTIGATION , cilt.125, sa.2, ss.636-651, 2015 (SCI-Expanded, Scopus)

29. Overexpression of miR-145-5p Inhibits Proliferation of Prostate Cancer Cells and Reduces SOX2 Expression

ÖZEN M., Karatas O. F., Gulluoglu S., Bayrak O. F., Sevli S., Guzel E., et al.

CANCER INVESTIGATION , cilt.33, sa.6, ss.251-258, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools

Canturk K. M., Ozdemir M., CAN Y. S. C., ÖNER K. S., Emre R., Aslan H., et al.

MOLECULAR BIOLOGY REPORTS , cilt.41, sa.12, ss.8127-8135, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Differential Expression of Stem Cell Markers and ABCG2 in Recurrent Prostate Cancer

Guzel E., KARATAŞ Ö., Duz M. B., Solak M., Ittmann M., ÖZEN M.

PROSTATE , cilt.74, sa.15, ss.1498-1505, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells

Ekin A., Karatas O. F., Culha M., ÖZEN M.

JOURNAL OF GENE MEDICINE , cilt.16, sa.11-12, ss.331-335, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Poikiloderma with Neutropenia: Genotype-Ethnic Origin Correlation, Expanding Phenotype and Literature Review

Koparir A., Gezdirici A., Koparir E., Ulucan H., YILMAZ M. Y., Erdemir A., et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A , cilt.164, sa.10, ss.2535-2540, 2014 (SCI-Expanded, Scopus)

34. Characterization of Stem-Like Cells Directly Isolated from Freshly Resected Laryngeal Squamous Cell Carcinoma Specimens

SUER İ., Karatas O. F., Yuceturk B., YILMAZ M. Y., Guven G., ÖZ A. B., et al.

CURRENT STEM CELL RESEARCH & THERAPY , cilt.9, sa.4, ss.347-353, 2014 (SCI-Expanded, Scopus)

35. Current Status of the Use of Single-Nucleotide Polymorphisms in Forensic Practices

Canturk K. M., Emre R., Kinoglu K., Baspinar B., Sahin F., Ozen M.

GENETIC TESTING AND MOLECULAR BIOMARKERS , cilt.18, sa.7, ss.455-460, 2014 (SCI-Expanded, Scopus)

36. miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer

Karatas O. F., Guzel E., SUER İ., Ekici I. D., Caskurlu T., Creighton C. J., et al.

PLOS ONE , cilt.9, sa.6, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. The role of miRNAs in cancer: from pathogenesis to therapeutic implications

SEVEN M., Karatas O. F., Duz M. B., ÖZEN M.

FUTURE ONCOLOGY , cilt.10, sa.6, ss.1027-1048, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

38. Human CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function

Karaca E., Weitzer S., Pehlivan D., Shiraishi H., Gogakos T., Hanada T., et al.

CELL , cilt.157, sa.3, ss.636-650, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. A novel frameshift mutation and infrequent clinical findings in two cases with Dyggve-Melchior-Clausen syndrome

SEVEN M., Koparir E., Gezdirici A., Aydin H., Skladny H., Fenercioglu E., et al.

CLINICAL DYSMORPHOLOGY , cilt.23, sa.1, ss.1-7, 2014 (SCI-Expanded, Scopus)

40. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas

Bayrak O. F., Gulluoglu S., Aydemir E., Ture U., Acar H., Atalay B., et al.

JOURNAL OF NEURO-ONCOLOGY , cilt.115, sa.2, ss.143-151, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

41. A novel EFNB1 mutation in a patient with craniofrontonasal syndrome and right hallux duplication

SEVEN M., Gezdirici A., Ulucan H., Karatas O. F., Yosunkaya E., Yuksel A., et al.

GENE , cilt.527, sa.2, ss.675-678, 2013 (SCI-Expanded)

42. MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients

Karatas O. F., Guzel E., Karaca E., Sevli S., Soyucen E., Yuksel A., et al.

MOLECULAR BIOLOGY REPORTS , cilt.40, sa.7, ss.4619-4623, 2013 (SCI-Expanded, Scopus)

43. Circumferential skin folds and multiple anomalies: confirmation of a distinct autosomal recessive Michelin tire baby syndrome

Ulucan H., Koparir E., Koparir A., Karaca E., Emre R., Gezdirici A., et al.

CLINICAL DYSMORPHOLOGY , cilt.22, sa.2, ss.87-90, 2013 (SCI-Expanded, Scopus)

44. A rare case of split hand/foot malformation with sensorineural hearing loss and Mondini dysplasia

Gezdirici A., YENİGÜN A., Koparir E., Yosunkaya E., Ulucan H., SEVEN M., et al.

CLINICAL DYSMORPHOLOGY , cilt.22, sa.1, ss.33-35, 2013 (SCI-Expanded, Scopus)

45. Identification of a novel mutation in ZAP70 and prenatal diagnosis in a Turkish family with severe combined immunodeficiency disorder

Karaca E., Karakoc-Aydiner E., Bayrak O. F., Keles S., Sevli S., Barlan I. B., et al.

GENE , cilt.512, sa.2, ss.189-193, 2013 (SCI-Expanded, Scopus)

46. Characterization of cancer stem-like cells in chordoma Laboratory investigation

Aydemir E., Bayrak O. F., Sahin F., Atalay B., Kose G. T., Ozen M., et al.

JOURNAL OF NEUROSURGERY , cilt.116, sa.4, ss.810-820, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. The effects of chemotherapeutic agents on differentiated chordoma cells

Bayrak O. F., Aydemir E., Gulluoglu S., Sahin F., Sevli S., Yalvac M. E., et al.

JOURNAL OF NEUROSURGERY-SPINE , cilt.15, sa.6, ss.620-624, 2011 (SCI-Expanded, Scopus)

48. The function of microRNAs, small but potent molecules, in human prostate cancer

Sevli S., Uzumcu A., Solak M., Ittmann M., Ozen M.

PROSTATE CANCER AND PROSTATIC DISEASES , cilt.13, sa.3, ss.208-217, 2010 (SCI-Expanded, Scopus)

49. Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer

Dakhova O., Ozen M., Creighton C. J., Li R., Ayala G., Rowley D., et al.

CLINICAL CANCER RESEARCH , cilt.15, sa.12, ss.3979-3989, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. Genomic Profiling of Prostate Cancers from African American Men

Ittmann M., Castro P., Creighton C. J., Ozen M., Berel D., Mims M. P.

NEOPLASIA , cilt.11, sa.3, ss.305-312, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. THE ROLE OF MICRORNA (miRNA)s AS A NOVEL TOOL IN CANCER DIAGNOSIS AND THERAPY

Uzumcu A., Tekguc M., Sevli S., Bayrak O. F., Ozen M.

IUBMB LIFE , cilt.61, sa.3, ss.298, 2009 (SCI-Expanded, Scopus)

52. Widespread deregulation of microRNA expression in human prostate cancer

Ozen M., Creighton C. J., Ozdemir M., Ittmann M.

ONCOGENE , cilt.27, sa.12, ss.1788-1793, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Oxygen tension directs chondrogenic differentiation of myelo-monocytic progenitors during endochondral bone formation

Shafer J., Davis A. R., Gannon F. H., Fouletier-Dilling C. M., Lazard Z., Moran K., et al.

TISSUE ENGINEERING , cilt.13, sa.8, ss.2011-2019, 2007 (SCI-Expanded)

54. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach

Dai H., Li R., Wheeler T., Ozen M., Ittmann M., Anderson M., et al.

HUMAN PATHOLOGY , cilt.38, sa.2, ss.299-307, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

55. Hypoxic adipocytes pattern early heterotopic bone formation

Olmsted-Davis E., Gannon F. H., Ozen M., Ittmann M. M., Gugala Z., Hipp J. A., et al.

AMERICAN JOURNAL OF PATHOLOGY , cilt.170, sa.2, ss.620-632, 2007 (SCI-Expanded, Scopus)

56. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway

Yan J., Yu C., Ozen M., Ittmann N., Tsai S. Y., Tsai M.

CANCER RESEARCH , cilt.66, sa.22, ss.11039-11046, 2006 (SCI-Expanded, Scopus)

57. SRC-3/AIB1 coordinately regulates cell proliferation and anti-apoptotic gene expression programs

Yan J., Ozen M., Ittmann M. M., Tsai S. Y., Tsai M.

CANCER RESEARCH , cilt.66, sa.8, 2006 (SCI-Expanded, Scopus)

58. Gene expression profiling and analysis of signaling pathways involved in priming and differentiation of human neural stem cells

Cai Y., Wu P., Ozen M., Yu Y., Wang J., Ittmann M., et al.

NEUROSCIENCE , cilt.138, sa.1, ss.133-148, 2006 (SCI-Expanded, Scopus)

59. Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer

Ozen M., Ittmann M.

CLINICAL CANCER RESEARCH , cilt.11, sa.13, ss.4701-4706, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. Bisphosphonates may inhibit development of atherosclerosis formation through its bactericidal effect on nanobacteria

Silay Y., Altundag K., Altundag O., Atik M., Ozen M.

MEDICAL HYPOTHESES , cilt.64, sa.6, ss.1239-1240, 2005 (SCI-Expanded)

61. The role of fibroblast growth factors and their receptors in prostate cancer

Kwabi-Addo B., Ozen M., Ittmann M.

ENDOCRINE-RELATED CANCER , cilt.11, sa.4, ss.709-724, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

62. Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor

Ozen M., Medreano E., Ittmann M.

MELANOMA RESEARCH , cilt.14, sa.1, ss.13-21, 2004 (SCI-Expanded, Scopus)

63. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation

Freeman K., Gangula R., Welm B., Ozen M., Foster B., Rosen J., et al.

CANCER RESEARCH , cilt.63, sa.19, ss.6237-6243, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

64. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer

Polnaszek N., Kwabi-Addo B., Peterson L., Ozen M., Greenberg N., Ortega S., et al.

CANCER RESEARCH , cilt.63, sa.18, ss.5754-5760, 2003 (SCI-Expanded, Scopus)

65. Role of fibroblast growth factor receptor signaling in prostate cancer cell survival

Ozen M., Giri D., Ropiquet F., Mansukhani A., Ittmann M.

JOURNAL OF THE NATIONAL CANCER INSTITUTE , cilt.93, sa.23, ss.1783-1790, 2001 (SCI-Expanded, Scopus)

66. Interleukin-6 is an autocrine growth factor in human prostate cancer

Giri D., Ozen M., Ittmann M.

AMERICAN JOURNAL OF PATHOLOGY , cilt.159, sa.6, ss.2159-2165, 2001 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Heterochromatin and interstitial telomeric DNA homology

Multani A., Ozen M., Furlong C., Zhao Y., Hsu T., Pathak S.

CHROMOSOMA , cilt.110, sa.3, ss.214-220, 2001 (SCI-Expanded, Scopus)

68. Caspase-dependent apoptosis induced by telomere cleavage and TRF2 loss

Multani A., Ozen M., Narayan S., Kumar V., Chandra J., McConkey D., et al.

NEOPLASIA , cilt.2, sa.4, ss.339-345, 2000 (SCI-Expanded, Scopus)

69. LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis

Thalmann G., Sikes R., Wu T., Degeorges A., Chang S., Ozen M., et al.

PROSTATE , cilt.44, sa.2, ss.91-103, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

70. Correlation of non-random chromosomal aberrations in lymphocytes of prostate cancer patients with specific clinical parameters

Ozen M., Hopwood V., Balbay M., Johnston D., Babaian R., Logothetis C., et al.

INTERNATIONAL JOURNAL OF ONCOLOGY , cilt.17, sa.1, ss.113-117, 2000 (SCI-Expanded)

71. Genetic alterations in human prostate cancer: A review of current literature

Ozen M., Pathak S.

ANTICANCER RESEARCH , cilt.20, sa.3B, ss.1905-1912, 2000 (SCI-Expanded, Scopus)

72. Amplification of telomeric DNA directly correlates with metastatic potential of human and murine cancers of various histological origin

Multani A., Ozen M., Sen S., Mandal A., Price J., Fan D., et al.

INTERNATIONAL JOURNAL OF ONCOLOGY , cilt.15, sa.3, ss.423-429, 1999 (SCI-Expanded, Scopus)

73. Amplification of the Y chromosome in three murine tumor cell lines transformed in vivo by different human prostate cancers

Multani A., Ozen M., Agrawal A., Hopwood V., Von Eschenbach A., Pathak S.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL , cilt.35, sa.4, ss.236-239, 1999 (SCI-Expanded, Scopus)

74. Aneuploidy index in blood: A potential marker for early onset, androgen response, and metastasis in human prostate cancer

Ozen M., Hopwood V., Johnston D., Babaian R., Logothetis C., von Eschenbach A., et al.

UROLOGY , cilt.53, sa.2, ss.381-385, 1999 (SCI-Expanded, Scopus)

75. Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with no decrease in telomerase activity

Multani A., Li C., Ozen M., Imam A., Wallace S., Pathak S.

ONCOLOGY REPORTS , cilt.6, sa.1, ss.39-44, 1999 (SCI-Expanded, Scopus)

76. Structural alterations of chromosome 5 in twelve human prostate cancer cell lines

Ozen M., Navone N., Multani A., Troncoso P., Logothetis C., Chung L., et al.

CANCER GENETICS AND CYTOGENETICS , cilt.106, sa.2, ss.105-109, 1998 (SCI-Expanded)

77. Telomeric DNA: Marker for human prostate cancer development?

Ozen M., Imam S., Datar R., Multani A., Narayanan R., Chung L., et al.

PROSTATE , cilt.36, sa.4, ss.264-271, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Dolastatin-10 induces polyploidy, telomeric associations and apoptosis in a murine melanoma cell line

Pathak S., Multani A., Ozen M., Richardson M., Newman R.

ONCOLOGY REPORTS , cilt.5, sa.2, ss.373-376, 1998 (SCI-Expanded, Scopus)

79. Establishment of two human prostate cancer cell lines derived from a single bone metastasis

Navone N., Olive M., Ozen M., Davis R., Troncoso P., Tu S., et al.

CLINICAL CANCER RESEARCH , cilt.3, sa.12, ss.2493-2500, 1997 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

80. Paclitaxel and water-soluble poly (L-glutamic acid) paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line

Multani A., Li C., Ozen M., Yadav M., Yu D., Wallace S., et al.

ANTICANCER RESEARCH , cilt.17, sa.6D, ss.4269-4274, 1997 (SCI-Expanded, Scopus)

81. Mutational inactivation of p53 tumor suppressor gene in two newly established human prostate cancer cell lines.

Ozen M., Mukhopadhyay T., Radinsky R., Chung L., Pathak S.

AMERICAN JOURNAL OF HUMAN GENETICS , cilt.61, sa.4, 1997 (SCI-Expanded, Scopus)

82. Specific histologic and cytogenetic evidence for in vivo malignant transformation of murine host cells by three human prostate cancer cell lines

Ozen M., Multani A., Kuniyasu H., Chung L., von Eschenbach A., Pathak S.

ONCOLOGY RESEARCH , cilt.9, sa.8, ss.433-438, 1997 (SCI-Expanded, Scopus)

83. Establishment of an in vitro cell model system to study human prostate carcinogenesis: Involvement of chromosome 5 in early stages of neoplastic transformation

Ozen M., Multani A., Chang S., VonEschenbach A., Chung L., Pathak S.

INTERNATIONAL JOURNAL OF ONCOLOGY , cilt.8, sa.5, ss.883-888, 1996 (SCI-Expanded, Scopus)

84. AG-NOR STUDIES IN A HUMAN LYMPHOCYTE CULTURE - ARE VARIANTS LOCALIZED TO SPECIFIC CHROMOSOMES

OZEN M., HOPWOOD V., PATHAK S.

AMERICAN JOURNAL OF MEDICAL GENETICS , cilt.59, sa.2, ss.225-228, 1995 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 17

1. Random Forest in Splice Site Prediction of Human Genome

Pashaei E., Ozen M., AYDIN N.

14th Mediterranean Conference on Medical and Biological Engineering and Computing (MEDICON), Paphos, CYPRUS, 31 Mart - 02 Nisan 2016, cilt.57, ss.512-517, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

2. Splice sites prediction of Human genome using AdaBoost

Pashaei E., Ozen M., AYDIN N.

3rd IEEE EMBS International Conference on Biomedical and Health Informatics (IEEE BHI), Nevada, Amerika Birleşik Devletleri, 24 - 27 Şubat 2016, ss.300-303, (Tam Metin Bildiri)

3. Prediction of Splice Site Using AdaBoost with a new sequence encoding approach

Pashaei E., YILMAZ A., Ozen M., AYDIN N.

IEEE International Conference on Systems, Man, and Cybernetics (SMC), Budapest, Macaristan, 9 - 12 Ekim 2016, ss.3853-3858, (Tam Metin Bildiri)

4. Gene Selection and Classification Approach for Microarray Data based on Random Forest Ranking and BBHA

Pashaei E., Ozen M., AYDIN N.

3rd IEEE EMBS International Conference on Biomedical and Health Informatics (IEEE BHI), Nevada, Amerika Birleşik Devletleri, 24 - 27 Şubat 2016, ss.308-311, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

5. A Novel Method for Splice Sites Prediction Using Sequence Component and Hidden Markov Model

Pashaei E., YILMAZ A., Ozen M., AYDIN N.

38th Annual International Conference of the IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC), Florida, Amerika Birleşik Devletleri, 16 - 20 Ağustos 2016, ss.3076-3079, (Tam Metin Bildiri)

6. Biomarker Discovery based on BBHA and AdaboostM1 on Microarray Data for Cancer Classification

Pashaei E., Ozen M., AYDIN N.

38th Annual International Conference of the IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC), Florida, Amerika Birleşik Devletleri, 16 - 20 Ağustos 2016, ss.3080-3083, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

7. Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension

Cengiz M., Yavuzer S., Yuruyen M., Yavuzer H., Dikici S. A., Avci B. K., et al.

Congress of the European-Society-of-Cardiology (ESC), London, Kanada, 29 Ağustos - 02 Eylül 2015, cilt.36, ss.326, (Özet Bildiri)

8. A Novel Gene Selection Algorithm for cancer identification based on Random Forest and Particle Swarm Optimization

Pashaei E., Ozen M., AYDIN N.

IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology CIBCB, Hawaii, Amerika Birleşik Devletleri, 12 - 15 Ağustos 2015, ss.67-72, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

9. Improving Medical Diagnosis Reliability Using Boosted C5.0 Decision Tree empowered by Particle Swarm Optimization

Pashaei E., ÖZEN M., AYDIN N.

37th Annual International Conference of the IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC), Milan, İtalya, 25 - 29 Ağustos 2015, ss.7230-7233, (Tam Metin Bildiri)

10. The effects of chemotherapeutic agents on differentiated chordoma cells

Aydemir E., Bayrak O. F., Ozen M., Sahin F.

35th Congress of the Federation-of-European-Biochemical-Societies, Gothenburg, İsveç, 26 Haziran - 01 Temmuz 2010, cilt.277, ss.161, (Özet Bildiri)

11. Determination of microRNAs involved in genomic instability in prostate cancer cells

Demir Z., Sevli S., Bayrak O., Ozen M.

7th European Cytogenetics Conference, Stockholm, İsveç, 4 - 07 Temmuz 2009, cilt.17, ss.113, (Özet Bildiri)

12. Bone tissue engineering: A model for delineating the early events in endochondral bone formation.

Gannon F. H., Shaffer J., Alan D., Fouletier-Dilling C., Lazard Z., Moran K., et al.

28th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, Pennsylvania, Amerika Birleşik Devletleri, 15 - 19 Eylül 2006, cilt.21, (Özet Bildiri)

13. Hypoxic adipocytes support early heterotopic bone formation.

Davis A., Gannon F. H., Ozen M., Ittmann M., Gugala Z., Hipp J., et al.

28th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, Pennsylvania, Amerika Birleşik Devletleri, 15 - 19 Eylül 2006, cilt.21, (Özet Bildiri)

14. Molecular profiling of differentially expressed genes in response to FGFR disruption in prostate cancer.

Ozen M., Dixit S., Ittmann M.

Annual Meeting of the Association-for-Molecular-Pathology, Arizona, Amerika Birleşik Devletleri, 11 - 13 Kasım 2005, cilt.7, ss.680, (Özet Bildiri)

15. Gene expression profile changes using CDNA microarray technology in patients with neurogenic bladder secondary to spinal cord injury

Evans J., Lai H., Ozen M., Krishnan B., Ittmann M., Smith C., et al.

Annual Meeting of the American-Urological-Association, San-Antonio, Kuzey Mariana Adaları, 21 - 26 Mayıs 2005, cilt.173, ss.308, (Özet Bildiri)

16. Artificial neural network analysis of DNA microarray-based prostate cancer recurrence

Peterson L., Ozen M., Erdem H., Amini A., Gomez L., Nelson C., et al.

2nd IEEE Symposium on Computational Intelligence in Bioformatics and Computational Biology, California, Amerika Birleşik Devletleri, 14 - 15 Kasım 2005, ss.275-282, (Tam Metin Bildiri)

17. Increased CDC25C phosphatase activity in prostate cancer: Correlation to biochemical recurrence

Ozen M., Ittmann M., DeBakey M.

Annual Meeting of the Association-for-Molecular-Pathology, Los-Angeles, Şili, 10 - 13 Kasım 2004, cilt.6, ss.431, (Özet Bildiri)

Metrikler

Yayın

101

Yayın (WoS)

101

Yayın (Scopus)

Atıf (WoS)

4421

H-İndeks (WoS)

Atıf (Scopus)

1156

H-İndeks (Scopus)

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)